Adipocyte (Pro)Renin-Receptor Deficiency Induces Lipodystrophy, Liver Steatosis and Increases Blood Pressure in Male Mice

Hypertension

Volumn 68, Issue 1, 2016, Pages 213-219

  Wu, Chia Hua ^a   Mohammadmoradi, Shayan ^a   Thompson, Joel ^b   Su, Wen ^a   Gong, Ming ^a   Nguyen, Genevieve ^c   Yiannikouris, Frédérique ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c INSERM   (France)

Author keywords

adipocytes; blood pressure; glucose; insulin; lipids; prorenin receptor

Indexed keywords

INSULIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PRORENIN RECEPTOR; SMALL INTERFERING RNA; ADIPONECTIN; ADIPOQ PROTEIN, MOUSE; GLUCOSE BLOOD LEVEL;

ADIPOCYTE; ADIPOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET INDUCED OBESITY; FATTY LIVER; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; HYPERTENSION; IN VITRO STUDY; INSULIN BLOOD LEVEL; LIPID DIET; LIPODYSTROPHY; LOW FAT DIET; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEFICIENCY; SYSTOLIC BLOOD PRESSURE; ANALYSIS; ANALYSIS OF VARIANCE; ANIMAL; C57BL MOUSE; DEFICIENCY; DISEASE MODEL; GLUCOSE BLOOD LEVEL; METABOLISM; OBESITY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; RANDOMIZATION; TRANSGENIC MOUSE;

ADIPOCYTES; ADIPONECTIN; ANALYSIS OF VARIANCE; ANIMALS; BLOOD GLUCOSE; DISEASE MODELS, ANIMAL; FATTY LIVER; HYPERTENSION; INSULIN; LIPODYSTROPHY; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OBESITY; PREDICTIVE VALUE OF TESTS; RANDOM ALLOCATION;

EID: 84966784611     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.115.06954     Document Type: Article

References (38)

1. Cutler JA, Sorlie PD, Wolz M, Thom T, Fields LE, Roccella EJ. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension. 2008;52:818-827. doi: 10.1161/HYPERTENSIONAHA.108.113357.
2. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA. 2010;303:2043-2050. doi: 10.1001/jama.2010.650.
3. Yiannikouris F, Gupte M, Putnam K, Thatcher S, Charnigo R, Rateri DL, Daugherty A, Cassis LA. Adipocyte deficiency of angiotensinogen prevents obesity-induced hypertension in male mice. Hypertension. 2012;60:1524-1530. doi: 10.1161/HYPERTENSIONAHA.112.192690.
4. Yiannikouris F, Wang Y, Shoemaker R, Larian N, Thompson J, English VL, Charnigo R, Su W, Gong M, Cassis LA. Deficiency of angiotensinogen in hepatocytes markedly decreases blood pressure in lean and obese male mice. Hypertension. 2015;66:836-842. doi: 10.1161/HYPERTENSIONAHA.115.06040.
5. Cassis LA, Police SB, Yiannikouris F, Thatcher SE. Local adipose tissue renin-angiotensin system. Curr Hypertens Rep. 2008;10:93-98.
6. Thatcher S, Yiannikouris F, Gupte M, Cassis L. The adipose reninangiotensin system: role in cardiovascular disease. Mol Cell Endocrinol. 2009;302:111-117.
7. Achard V, Tassistro V, Boullu-Ciocca S, Grino M. Expression and nutritional regulation of the (pro)renin receptor in rat visceral adipose tissue. J Endocrinol Invest. 2011;34:840-846. doi: 10.3275/7627.
8. Achard V, Boullu-Ciocca S, Desbriere R, Nguyen G, Grino M. Renin receptor expression in human adipose tissue. Am J Physiol Regul Integr Comp Physiol. 2007;292:R274-R282. doi: 10.1152/ajpregu.00439.2005.
9. Tan P, Shamansurova Z, Bisotto S, Michel C, Gauthier MS, Rabasa-Lhoret R, Nguyen TM, Schiller PW, Gutkowska J, Lavoie JL. Impact of the prorenin/renin receptor on the development of obesity and associated cardiometabolic risk factors. Obesity (Silver Spring). 2014;22:2201-2209. doi: 10.1002/oby.20844.
10. Nabi AH, Kageshima A, Uddin MN, Nakagawa T, Park EY, Suzuki F. Binding properties of rat prorenin and renin to the recombinant rat renin/prorenin receptor prepared by a baculovirus expression system. Int J Mol Med. 2006;18:483-488.
11. Nguyen G, Blanchard A, Curis E, Bergerot D, Chambon Y, Hirose T, Caumont-Prim A, Tabard SB, Baron S, Frank M, Totsune K, Azizi M. Plasma soluble (pro)renin receptor is independent of plasma renin, prorenin, and aldosterone concentrations but is affected by ethnicity. Hypertension. 2014;63:297-302. doi: 10.1161/HYPERTENSIONAHA. 113.02217.
12. Burcklé CA, Jan Danser AH, Müller DN, Garrelds IM, Gasc JM, Popova E, Plehm R, Peters J, Bader M, Nguyen G. Elevated blood pressure and heart rate in human renin receptor transgenic rats. Hypertension. 2006;47:552-556. doi: 10.1161/01.HYP.0000199912.47657.04.
13. Li W, Peng H, Cao T, Sato R, McDaniels SJ, Kobori H, Navar LG, Feng Y. Brain-targeted (pro)renin receptor knockdown attenuates angiotensin II-dependent hypertension. Hypertension. 2012;59:1188-1194. doi: 10.1161/HYPERTENSIONAHA.111.190108.
14. Cousin C, Bracquart D, Contrepas A, Corvol P, Muller L, Nguyen G. Soluble form of the (pro)renin receptor generated by intracellular cleavage by furin is secreted in plasma. Hypertension. 2009;53:1077-1082. doi: 10.1161/HYPERTENSIONAHA.108.127258.
15. Biswas KB, Nabi AN, Arai Y, Nakagawa T, Ebihara A, Ichihara A, Inagami T, Suzuki F. Qualitative and quantitative analyses of (pro)renin receptor in the medium of cultured human umbilical vein endothelial cells. Hypertens Res. 2011;34:735-739. doi: 10.1038/hr.2011.26.
16. Gonzalez AA, Lara LS, Luffman C, Seth DM, Prieto MC. Soluble form of the (pro)renin receptor is augmented in the collecting duct and urine of chronic angiotensin II-dependent hypertensive rats. Hypertension. 2011;57:859-864. doi: 10.1161/HYPERTENSIONAHA.110.167957.
17. Nguyen G, Delarue F, Burcklé C, Bouzhir L, Giller T, Sraer JD. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest. 2002;109:1417-1427. doi: 10.1172/JCI14276.
18. Watanabe N, Bokuda K, Fujiwara T, Suzuki T, Mito A, Morimoto S, Jwa SC, Egawa M, Arai Y, Suzuki F, Sago H, Ichihara A. Soluble (pro)renin receptor and blood pressure during pregnancy: a prospective cohort study. Hypertension. 2012;60:1250-1256. doi: 10.1161/HYPERTENSIONAHA.112.197418.
19. Hamada K, Taniguchi Y, Shimamura Y, et al. Serum level of soluble (pro) renin receptor is modulated in chronic kidney disease. Clin Exp Nephrol. 2013;17:848-856. doi: 10.1007/s10157-013-0803-y.
20. Burcklé C, Bader M. Prorenin and its ancient receptor. Hypertension. 2006;48:549-551. doi: 10.1161/01.HYP.0000241132.48495.df.
21. Kinouchi K, Ichihara A, Sano M, Sun-Wada GH, Wada Y, Kurauchi-Mito A, Bokuda K, Narita T, Oshima Y, Sakoda M, Tamai Y, Sato H, Fukuda K, Itoh H. The (pro)renin receptor/ATP6AP2 is essential for vacuolar H+-ATPase assembly in murine cardiomyocytes. Circ Res. 2010;107:30-34 doi: 10.1161/CIRCRESAHA.110.224667.
22. Müller DN, Binger KJ, Riediger F. Prorenin receptor regulates more than the renin-angiotensin system. Ann Med. 2012;44(suppl 1):S43-S48. doi: 10.3109/07853890.2012.660496.
23. Reudelhuber TL. The interaction between prorenin, renin and the (pro) renin receptor: time to rethink the role in hypertension. Curr Opin Nephrol Hypertens. 2012;21:137-141. doi: 10.1097/MNH.0b013e3283500927.
24. Riediger F, Quack I, Qadri F, et al. Prorenin receptor is essential for podocyte autophagy and survival. J Am Soc Nephrol. 2011;22:2193-2202. doi: 10.1681/ASN.2011020200.
25. Cruciat CM, Ohkawara B, Acebron SP, Karaulanov E, Reinhard C, Ingelfinger D, Boutros M, Niehrs C. Requirement of prorenin receptor and vacuolar H+-ATPase-mediated acidification for Wnt signaling. Science. 2010;327:459-463. doi: 10.1126/science.1179802.
26. Ray BS. Of Wnt, Prorenin Receptor, and V-AT Pase. Sci. Signal. 2010;3: 329.
27. Zimmerman AW, Veerkamp JH. New insights into the structure and function of fatty acid-binding proteins. Cell Mol Life Sci. 2002;59:1096-1116.
28. Reue K, Péterfy M. Mouse models of lipodystrophy. Curr Atheroscler Rep. 2000;2:390-396.
29. Savage DB. Mouse models of inherited lipodystrophy. Dis Model Mech. 2009;2:554-562. doi: 10.1242/dmm.002907.
30. Tsai YS, Kim HJ, Takahashi N, Kim HS, Hagaman JR, Kim JK, Maeda N. Hypertension and abnormal fat distribution but not insulin resistance in mice with P465L PPARgamma. J Clin Invest. 2004;114:240-249. doi: 10.1172/JCI20964.
31. Brown JM, Betters JL, Lord C, et al. CGI-58 knockdown in mice causes hepatic steatosis but prevents diet-induced obesity and glucose intolerance. J Lipid Res. 2010;51:3306-3315. doi: 10.1194/jlr.M010256.
32. Simonds SE, Pryor JT, Ravussin E, et al. Leptin mediates the increase in blood pressure associated with obesity. Cell. 2014;159:1404-1416. doi: 10.1016/j.cell.2014.10.058.
33. Canbakan B, Tahan V, Balci H, Hatemi I, Erer B, Ozbay G, Sut N, Hacibekiroglu M, Imeryuz N, Senturk H. Leptin in nonalcoholic fatty liver disease. Ann Hepatol. 2008;7:249-254.
34. Fukushima A, Kinugawa S, Homma T, Masaki Y, Furihata T, Abe T, Suga T, Takada S, Kadoguchi T, Okita K, Matsushima S, Tsutsui H. Increased plasma soluble (pro)renin receptor levels are correlated with renal dysfunction in patients with heart failure. Int J Cardiol. 2013;168:4313-4314. doi: 10.1016/j.ijcard.2013.04.176.
35. Engeli S, Böhnke J, Gorzelniak K, Janke J, Schling P, Bader M, Luft FC, Sharma AM. Weight loss and the renin-angiotensin-aldosterone system. Hypertension. 2005;45:356-362. doi: 10.1161/01. HYP.0000154361.47683.d3.
36. Massiéra F, Bloch-Faure M, Ceiler D, Murakami K, Fukamizu A, Gasc JM, Quignard-Boulange A, Negrel R, Ailhaud G, Seydoux J, Meneton P, Teboul M. Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation. FASEB J. 2001;15:2727-2729. doi: 10.1096/fj.01-0457fje.
37. Matsusaka T, Niimura F, Shimizu A, Pastan I, Saito A, Kobori H, Nishiyama A, Ichikawa I. Liver angiotensinogen is the primary source of renal angiotensin II. J Am Soc Nephrol. 2012;23:1181-1189. doi: 10.1681/ASN.2011121159.
38. Carroll WX, Kalupahana NS, Booker SL, Siriwardhana N, Lemieux M, Saxton AM, Moustaid-Moussa N. Angiotensinogen gene silencing reduces markers of lipid accumulation and inflammation in cultured adipocytes. Front Endocrinol (Lausanne). 2013;4:10. doi: 10.3389/fendo.2013.00010.